IInbiomotion — Series A · €2M
Ysios Capital led a €2M Series A in the IRB Barcelona spin-off, with Fundació Vila Casas and JVRisk Technologies also taking part. The money was for validating its bone-metastasis biomarker (MAF) in clinical studies and moving towards a regulatory filing.
LeadYsios Capital
RoundSeries A
Announced28 Jun 2012
CityBarcelona
SectorHealthtech & Bio · Healthtech / Precision oncology diagnostics
Source
Y
Y
